Abstract

Disposing of Expired Drugs and Chemicals: New Options for Compounders

Author(s): Vail Jane

Issue: Jan/Feb 2008 - Compounding for Hospice and Cancer Patients

Page(s): 38-47

Download in electronic PDF format for $75

Abstract

Years ago, pharmacists disposed of expired drugs and chemicals by incinerating them, flushing them down the toilet, washing them down the sink, or attempting to return them to the manufacturer. Some of those methods of disposal have proven over time to exert a devastating effect on the environment (and often on the local community), and compliance with state and federal regulations for the management of expired drugs has become essential to avoid incurring fines and to protect the public welfare. Now, pharmacists who must navigate the complexities of that effort have professional allies. Over the last decade, the disposal of hazardous pharmaceutical waste has become a science, and companies with expertise in that specialty are increasing in number. In this article, information about several pharmaceutical waste disposal or returns companies is compared, and criteria for selecting a drug disposal service are presented.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2008 Pg. 38-47 View Sample	Disposing of Expired Drugs and Chemicals: New Options for Compounders Author(s): Vail Jane
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 87	PostScription: Consumer Options for Disposal of Unused Medications Author(s): Vail Jane
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
Jul/Aug 2002 Pg. 271-273	Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Author(s): Kramer Mark A, Grilley Bambi J
May/Jun 2004 Pg. 210	Standard Operating Procedure: Disposal of Chemicals Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 182-190	Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Author(s): Mixon Bill, Nain John
Mar/Apr 2010 Pg. 131-133	Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Author(s): Burke John, Hill Jeff
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
Sep/Oct 2010 Pg. 366-369	Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response Author(s): Briggs Valerie
Jul/Aug 2007 Pg. 350-351	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David